Megha Prasad is a Cardiology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 184 publications with 3,452 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
127 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
127 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.7%Beta blocker18.3%Metoprolol Succinate38%Metoprolol Tartrate36%Carvedilol26%Part D<11 patientsStatin17.4%Atorvastatin Calcium55%Rosuvastatin Calcium45%Part D<11 patients+ 5 more classes in this area
Blood & clotting
14.4%P2Y12 inhibitor9.6%Clopidogrel100%Part D≥15 patientsFactor Xa inhibitor4.8%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
6.9%SGLT2 inhibitor3.6%Jardiance100%Part D<11 patientsAntidiarrheal microorganisms3.3%Folic Acid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comprehensive Management of ANOCA, Part 1—Definition, Patient Population, and Diagnosis
Journal of the American College of Cardiology
2023 - Comprehensive Management of ANOCA, Part 2—Program Development, Treatment, and Research Initiatives
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Honig, MD, PhD
NewYork–Presbyterian Hospital
Nasser Altorki, MD
NewYork–Presbyterian Hospital
Michael Niederman, MD
NewYork–Presbyterian Hospital
Shunichi Homma, MD
NewYork–Presbyterian Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”